Bank of New York Mellon’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-164,511
| Closed | -$2.59M | – | 4643 |
|
|
2022
Q2 | $2.59M | Sell |
164,511
-27,663
| -14% | -$422K | ﹤0.01% | 2682 |
|
|
2022
Q1 | $2.92M | Sell |
192,174
-4,414
| -2% | -$67.2K | ﹤0.01% | 2720 |
|
|
2021
Q4 | $3.02M | Sell |
196,588
-22,929
| -10% | -$302K | ﹤0.01% | 2747 |
|
|
2021
Q3 | $1.91M | Buy |
219,517
+10,398
| +5% | +$94.8K | ﹤0.01% | 2999 |
|
|
2021
Q2 | $2.13M | Sell |
209,119
-39,416
| -16% | -$416K | ﹤0.01% | 2942 |
|
|
2021
Q1 | $2.97M | Buy |
248,535
+969
| +0.4% | +$11K | ﹤0.01% | 2693 |
|
|
2020
Q4 | $2.25M | Buy |
247,566
+63,555
| +35% | +$492K | ﹤0.01% | 2775 |
|
|
2020
Q3 | $1.12M | Buy |
184,011
+3,070
| +2% | +$23.4K | ﹤0.01% | 3056 |
|
|
2020
Q2 | $1.61M | Buy |
180,941
+32,195
| +22% | +$278K | ﹤0.01% | 2805 |
|
|
2020
Q1 | $1.08M | Buy |
148,746
+661
| +0.4% | +$4.9K | ﹤0.01% | 2921 |
|
|
2019
Q4 | $1.31M | Buy |
148,085
+4,178
| +3% | +$31.3K | ﹤0.01% | 3094 |
|
|
2019
Q3 | $876K | Buy |
143,907
+10,495
| +8% | +$59K | ﹤0.01% | 3241 |
|
|
2019
Q2 | $558K | Sell |
133,412
-15,730
| -11% | -$82.9K | ﹤0.01% | 3546 |
|
|
2019
Q1 | $938K | Buy |
149,142
+2,670
| +2% | +$18.7K | ﹤0.01% | 3230 |
|
|
2018
Q4 | $949K | Buy |
146,472
+8,130
| +6% | +$62.2K | ﹤0.01% | 3139 |
|
|
2018
Q3 | $1.15M | Buy |
138,342
+8,948
| +7% | +$68.1K | ﹤0.01% | 3189 |
|
|
2018
Q2 | $806K | Buy |
129,394
+115
| +0.1% | +$731 | ﹤0.01% | 3369 |
|
|
2018
Q1 | $885K | Buy |
129,279
+4,771
| +4% | +$30.3K | ﹤0.01% | 3287 |
|
|
2017
Q4 | $819K | Sell |
124,508
-21,871
| -15% | -$134K | ﹤0.01% | 3362 |
|
|
2017
Q3 | $814K | Sell |
146,379
-5,719
| -4% | -$38.6K | ﹤0.01% | 3343 |
|
|
2017
Q2 | $1.17M | Buy |
152,098
+24,260
| +19% | +$205K | ﹤0.01% | 3159 |
|
|
2017
Q1 | $1.15M | Buy |
127,838
+6,581
| +5% | +$68.6K | ﹤0.01% | 3165 |
|
|
2016
Q4 | $1.31M | Sell |
121,257
-39,106
| -24% | -$521K | ﹤0.01% | 3108 |
|
|
2016
Q3 | $2.62M | Buy |
160,363
+51,606
| +47% | +$726K | ﹤0.01% | 2591 |
|
|
2016
Q2 | $1.04M | Sell |
108,757
-54,296
| -33% | -$591K | ﹤0.01% | 3108 |
|
|
2016
Q1 | $2.29M | Sell |
163,053
-15,799
| -9% | -$163K | ﹤0.01% | 2579 |
|
|
2015
Q4 | $1.94M | Buy |
178,852
+13,466
| +8% | +$122K | ﹤0.01% | 2731 |
|
|
2015
Q3 | $1.13M | Sell |
165,386
-23,513
| -12% | -$182K | ﹤0.01% | 3114 |
|
|
2015
Q2 | $1.72M | Buy |
188,899
+173,420
| +1,120% | +$1.31M | ﹤0.01% | 3017 |
|
|
2015
Q1 | $105K | Buy |
15,479
+141
| +0.9% | +$567 | ﹤0.01% | 4029 |
|
|
2014
Q4 | $52K | Hold |
15,338
| – | – | ﹤0.01% | 4140 |
|
|
2014
Q3 | $51K | Hold |
15,338
| – | – | ﹤0.01% | 4143 |
|
|
2014
Q2 | $64K | Sell |
15,338
-64,448
| -81% | -$341K | ﹤0.01% | 4050 |
|
|
2014
Q1 | $633K | Sell |
79,786
-1,830
| -2% | -$13.6K | ﹤0.01% | 3496 |
|
|
2013
Q4 | $577K | Buy |
81,616
+3,374
| +4% | +$22.5K | ﹤0.01% | 3531 |
|
|
2013
Q3 | $579K | Buy |
78,242
+6,726
| +9% | +$52.3K | ﹤0.01% | 3466 |
|
|
2013
Q2 | $621K | Buy |
+71,516
| New | +$460K | ﹤0.01% | 3417 |
|
Other funds holding NPTN
Bank of New York Mellon's NPTN Position: Q3 2022 in Review
Bank of New York Mellon sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 164,511 shares — an estimated $2.59M sold.
Bank of New York Mellon first reported a position in NPTN in Q2 2013 and held it in 37 quarters. The position peaked at $3.02M in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Bank of New York Mellon reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Bank of New York Mellon sold 164,511 NEOPHOTONICS CORP shares in Q3 2022, an estimated $2.59M.
- Bank of New York Mellon first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 37 quarters.
- Bank of New York Mellon's NEOPHOTONICS CORP position peaked at $3.02M in Q4 2021.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.